Coutiño Hugo-Enrique, Ströker Erwin, Takarada Ken, Mugnai Giacomo, Abugattas Juan-Pablo, Sieira Juan, Salghetti Francesca, Terasawa Muryo, Varnavas Varnavas, Maj Riccardo, Osório Thiago Guimarães, Neach Diego, Brugada Pedro, de Asmundis Carlo, Chierchia Gian-Battista
Heart Rhythm Management Centre, Postgraduate course in Cardiac Electrophysiology and Pacing, Vrije Universiteit Brussel, Universitair Ziekenhuis Brussel, Brussels, Belgium.
Pacing Clin Electrophysiol. 2019 Nov;42(11):1456-1462. doi: 10.1111/pace.13810. Epub 2019 Oct 10.
A left common pulmonary vein (LCPV) accounts as the most frequent pulmonary vein (PV) variation. Our aim was to compare the performance of radiofrequency (RF) versus second-generation cryoballoon (CB-A) ablation in patients with atrial fibrillation (AF) and LCPVs.
In a total cohort of 716 patients undergoing PV isolation with preprocedural CT-scanning, LCPV+ patients were selected with measurement of PV ostial area and trunk distance. All LCPV+ patients were matched between RF and CB-A group in a 1:1 ratio based on propensity scores, and compared for outcome.
Left common pulmonary veins were found in 31% (88/283) RF versus 34% (146/433) CB-A patients, respectively, (P = .44). In the matched population of 83 LCPV+ patients in each group, electrical isolation could be achieved in all left-sided PVs. No significant difference was noted for the rate of AF/left atrial tachyarrhythmia (LAT) recurrence between RF and CB-A group (30% vs 28%, P = .86), with similar AF/LAT-free survival (log rank, P = .71). There were 48 patients with AF/LAT recurrence (29%) during the follow-up. Recurrence rate between paroxysmal versus persistent AF was 27/120 (22.5%) versus 21/46 (46%), P = .004. Cox proportional regression analysis withheld LA volume and persistent AF as independent variables to predict AF/LAT recurrence. No increased hazard for AF/LAT recurrence was observed for patients with a long (>15 mm) vs short (5-15 mm) LCPV trunk (OR 1.14, 95% CI 0.6-2.2, P = .7).
In our study, equal efficacy and outcome was noted in LCPV+ patients between RF and CB-A technology.
左肺静脉是最常见的肺静脉变异类型。我们的目的是比较射频消融(RF)与第二代冷冻球囊消融(CB-A)治疗心房颤动(AF)合并左肺静脉(LCPV)患者的疗效。
在716例行肺静脉隔离术且术前进行CT扫描的患者队列中,选择LCPV+患者并测量肺静脉开口面积和主干长度。所有LCPV+患者根据倾向得分按1:1比例在RF组和CB-A组之间进行匹配,并比较治疗结果。
RF组和CB-A组分别有31%(88/283)和34%(146/433)的患者发现左肺静脉(P = 0.44)。在每组83例LCPV+患者的匹配人群中,所有左侧肺静脉均能实现电隔离。RF组和CB-A组之间AF/左房性心动过速(LAT)复发率无显著差异(30%对28%,P = 0.86),无AF/LAT生存情况相似(对数秩检验,P = 0.71)。随访期间有48例患者发生AF/LAT复发(29%)。阵发性AF与持续性AF的复发率分别为27/120(22.5%)和21/46(46%),P = 0.004。Cox比例回归分析将左房容积和持续性AF作为独立变量来预测AF/LAT复发。LCPV主干长(>15 mm)与短(5 - 15 mm)的患者AF/LAT复发风险未增加(OR 1.14,95% CI 0.6 - 2.2,P = 0.7)。
在我们的研究中,RF和CB-A技术治疗LCPV+患者的疗效和结果相当。